(Q37701737)

22 August 2017

1 reference

title

The diabetic cardiomyopathy (English)

1 reference

22 August 2017

Roberto Tarquini

1

1 reference

22 August 2017

Chiara Lazzeri

2

1 reference

22 August 2017

Laura Pala

3

1 reference

22 August 2017

Carlo Maria Rotella

4

1 reference

22 August 2017

Gian Franco Gensini

5

1 reference

22 August 2017

publication date

3 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

48

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

173-181

1 reference

Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

New type of cardiomyopathy associated with diabetic glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Evidence for cardiomyopathy in familial diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Diabetes and idiopathic cardiomyopathy: a nationwide case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Diabetic cardiomyopathy: the search for a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Long-chain acyl-coenzyme A esters and fatty acids directly link metabolism to K(ATP) channels in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Akt1 in the cardiovascular system: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Effects of glucagon-like peptide-1 and long-acting analogues on cardiovascular and metabolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

The effects of insulin and beta-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Cardiac carbohydrate metabolism in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Influence of alcohol intake and aldehyde dehydrogenase 2 phenotype on peripheral neuropathy of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

The impact of Cardiovascular Autonomic Neuropathy in diabetes: is it associated with left ventricular dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Overexpression of metallothionein reduces diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Alterations in ion channel physiology in diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Depressed cardiac myofilament function in human diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0180-X

10.1007/S00592-010-0180-X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference